The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis

Chen LiHong; Hu NaiZhong; Wang YaLei

Issue 10

Oct. 2011

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(10): 1044-1046+1054

PDF( 1398 KB)

The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis

Published Date: 2011-10-20

Abstract

Abstract

Objective To evaluate the value of MESO scoring system in predicting the prognosis of patients with decompensated cirrhosis and to compare the predictable value of MESO, MELD and CTP and to investigate the prognostic value of the combination of MESO and CTP in decompensated cirrhosis.Methods Here we present a retrospective cohort study of 179 decompensated cirrhotic hospitalized patients in gastrointestinal department or infectious department from september 2007 to september 2009.CTP, MELD, MESO score of each patient was calculated by using the information collected at the time of admission to our hospital respectively and the capacity of three scoring systems was evaluated for predicting the prognosis of cirrhotic patients according to the receiver characteristic curve and the area under the curve.Meanwhile, the relationship between the outcome of patients and MESO index within a single CTP class was investigated.Results 37 (20.67%) patients died within the first 3 months, MESO and MELD of 3-month death group are significantly higher than that of 3-month survival group (P<0.05) .MESO for predicting the 3-month prognosis is more efficient than MELD and CTP.Youden index is 60.92%, 37.31% and 30.12% respectively and AUC is 0.88, 0.86, 0.78 (P<0.05) respectively.Mortality in the group of MESO index more than 1.6 is higher than that in the group of MESO index less than 1.6 (P<0.05) within a single CTP class.Conclusion MESO is a useful predictor for short-and mediate-term prognosis in decompensated cirrhotic patients and it is better than MELD and CTP.Combination of MESO and CTP scoring system can predict the outcome of patients with cirrhosis more efficiently within a single class.
- liver cirrhosis,
- MELD,
- MESO

FullText(HTML)

References(10)

References

[1] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intra-hepatic portosystemic shunts[J]. Hepatology, 2000, 31 (4) : 864-871.

[2]Wiesner R, Edwards E, Freeman R, et al.The United net-work for organ sharing liver disease severity score commit-tee:Model for end-stage liver disease (MELD) and alloca-tion of donor livers[J].Gastroenterology, 2003, 124 (1) :91-96.

[3] Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting[J]. Am J Gastroenterol, 2003, 98 (5) : 1167-1174.

[4]Huo TI, WANG YW, Yang YY, et al.Model for end-stageliver disease score to serum sodium ratio index as a prognos-tic predictor and its correlation with portal pressure in patientswith liver cirrhosis[J].Liver Int, 2007, 27 (4) :498-506.

[5] Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation[J]. Liver Transpl, 2001, 7 (7) : 567-580.

[6]http://depts.washington.edu/uwhep/calculations/meld-score.htm.

[7] Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis[J]. Liver Transpl, 2008, 14 (6) : 837-844.

[8]Huo TI, Lin HC, Hsia CY, et al.The MELD-Na is an inde-pendent short-and long-term prognostic predictor for hep-atocellular carcinoma:a prospective survey[J].Dig LiverDis, 2008, 40 (11) :882-889.

[9] Biggins SW, Kim WR, Terrauh NA, et al. Evidence-based of serum sodium concentration incorporation into MELD[J]. Gastroenterology, 2006, 130 (6) : 1652-1660.

[10]Ruf AE, Kremers WK, Chavez LL, et al.Addition of serum so-dium into the MELD score predicts waiting list mortality betterthan MELD along[J].Liver Transpl, 2005, 11 (3) :336-343.

Relative Articles

[1]	Rigan XIGU, Ya SU, Jing TONG, Bingyuan WANG. Application of Model for End-Stage Liver Disease score in end-stage liver disease[J]. Journal of Clinical Hepatology, 2025, 41(3): 556-560. doi: 10.12449/JCH250325
[2]	Jianjun LIU, Wenkai ZHENG, Jianghong WANG, Yanjun REN, Yan LIU, Lizhen ZHAO. Vasoactive substance resistance mechanisms in diagnosis and treatment of end-stage liver diseases: Disputes and counter-measurement[J]. Journal of Clinical Hepatology, 2022, 38(10): 2408-2411. doi: 10.3969/j.issn.1001-5256.2022.10.040
[3]	Lu YANG, Ye XIONG, Jianrong HUANG. Application of human serum albumin in the management of end-stage liver disease[J]. Journal of Clinical Hepatology, 2022, 38(4): 936-941. doi: 10.3969/j.issn.1001-5256.2022.04.040
[4]	Yan WANG, Ying XU, Wei SUN, Li CHEN, Jianhe GAN, Jing GU. Value of interleukin-6 combined with Model for End-Stage Liver Disease score in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(8): 1774-1779. doi: 10.3969/j.issn.1001-5256.2022.08.011
[5]	Shaoyu DONG, Changyu SUN, Fangfang QIAO, Xiao LIU, Jianying ZHANG. Value of age and D-dimer combined with Model for End-Stage Liver Disease in predicting the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(11): 2478-2482. doi: 10.3969/j.issn.1001-5256.2022.11.008
[6]	Qin ZHAO, Junjie YANG, Yanping ZHONG, Shan LI, Yuanyuan LIU, Xu LEI, Long LIU, Huabing TAN. Association between myostatin and sarcopenia in end-stage liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2692-2700. doi: 10.3969/j.issn.1001-5256.2021.11.045
[7]	Jing GU, Yan WANG, Wei SUN, Weifeng ZHAO, Jianhe GAN. Value of interleukin-32 combined with Model for End-Stage Liver Disease in predicting the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(2): 304-308. doi: 10.3969/j.issn.1001-5256.2021.02.012
[8]	LIU ZhenLi, FAN ZuoPeng, LIU YaLi, ZHANG Jing. Value of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score in predicting the prognosis of patients with hepatic sinus obstruction syndrome associated with Gynura segetum( Lour. ) Merr.[J]. Journal of Clinical Hepatology, 2020, 36(11): 2462-2466. doi: 10.3969/j.issn.1001-5256.2020.11.013
[9]	Liu TianHui. Serological assessment of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 714-719. doi: 10.3969/j.issn.1001-5256.2019.04.003
[10]	Han XueJing, Xiao Ye, Sun Min. Comparative study between the value of MESO index and MELD-Na in the short-term prognosis of decompensated liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1187-1189.
[11]	Wu YunZhong, Wang XianBo, Ye Hang, Jiang YuYong, Sun FengXia, Wang RongBing. The effecacy of Jieduliangxuefa for the patients with chronic severe hepatitis B: using model for end-stage liver diseases (MELD)[J]. Journal of Clinical Hepatology, 2011, 27(5): 467-470.
[12]	Wang XiaoRen, Yan BingZhu, Yang BaoShan. The prognostic assessment of model for end-stage liver disease (MELD) and total bile acids in patients with subacute liver failure[J]. Journal of Clinical Hepatology, 2011, 27(6): 638-640.
[13]	Li JingYing, Lu LunGen. Progress of model for end-stage liver disease in the value of prognostic evaluation in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(7): 768-771+782.
[14]	Zheng XiaoLi, Wang LiangZhi, Wu BaoLi. Value of model for end-stage liver disease in prediction of prognosis in patients with decompensated hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(7): 738-740+745.
[15]	Zhan GuoQing, Tan HuaBing, Li Fang, Li RuGui, Zhang WeiWei, Li JinKe. Evaluation of model for end stage liver disease for estimation of short-term prognosis in decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 280-282.
[16]	Liu ZhiHong, Jiang JianNing, Luo GuangHan, Wu JiZhou, Deng YiMing, Su MingHua, Wu JianLin, Zhang Lu. The value of MELD score for evaluation of plasma exchange in patients with liver failure[J]. Journal of Clinical Hepatology, 2010, 26(6): 615-617.
[18]	Zhan GuoQing, Zheng SanJu, Zhu Lin, Wang ChongHui, Li JinKe, Zhang WeiWei. The analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the model for end-stage liver disease and Child-Pugh grading[J]. Journal of Clinical Hepatology, 2009, 25(2): 114-116.
[19]	Zhan GuoQing, Zheng SanJu, Zhu Lin, Li JinKe. A retrospective analysis of prognosis on patients with severe hepatitis using the model for end-stage liver disease[J]. Journal of Clinical Hepatology, 2008, 24(2): 98-100.
[20]	Bai PingPing, Po YunFeng, Qin JunJie. The analysis of the short-term prognostic of cirrhotic patients using the criterion of model for end-stage liver disease and Child-Pugh grading[J]. Journal of Clinical Hepatology, 2007, 23(3): 193-194.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3568) PDF downloads(721)

The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content